NSE SHARE TARGET PRICE

Nvidia still 'the one' for AI? BNP Paribas raises target to $345, sees up to 47% upside

BNP Paribas has retained its Outperform rating on Nvidia and raised its target price to $345 from $285, implying 47% upside. The brokerage sees Nvidia’s full-stack AI platform, including GPUs, networking and software, helping it navigate the shift towards increasingly complex inference workloads and sustain its market leadership.

CAS chaos eases? Jefferies names top stock picks as options volumes recover, IPOs and commodities gain traction

Jefferies sees signs of recovery in India’s derivatives market as options volumes rebound after the disruption caused by the closing auction session (CAS). BSE’s cash-market share also rose, while MCX benefited from stronger energy options activity. The brokerage expects Groww to benefit from improving orders, higher MTF volumes and commodity trading, and named Groww, MCX, KFIN and Nuvama as top picks

Nomura sees IndiGo emerging stronger from fuel shock; initiates Buy with Rs 6,000 target

Nomura initiated coverage on InterGlobe Aviation with a Buy rating and a Rs 6,000 target price, implying around 20% upside from the September 30 close. It believes IndiGo’s low-cost model, large aircraft order book and expanding international network could strengthen its competitive edge despite elevated fuel prices.

AceVector shares list at 12% discount to IPO price on BSE, NSE

The Rs 420-crore public issue was priced in the range of Rs 30–32 per share, with the upper end of the price band at Rs 32. The issue comprised a fresh issue of 8.97 crore shares aggregating to Rs 287 crore and an offer for sale (OFS) of 4.16 crore shares worth Rs 133 crore.

PB Fintech shares crash 50% from peak, fall below 2021 IPO price. More downside coming?

PB Fintech shares plunged 50% from their all-time high to drop below the 2021 IPO price of Rs 980. The sharp six-day selloff follows proposed IRDAI regulatory curbs on insurance distribution, prompting brokerages like Bernstein and Jefferies to cut target prices amid earnings pressure concerns.

Moneyview shares skyrocket 82% from IPO price after strong market debut. Should you buy, sell or hold?

Moneyview shares extended their strong debut gains on Thursday, rising as much as 82% from the IPO price. After listing at Rs 55.61 on the BSE, a 64% premium to the Rs 34 issue price, the stock climbed another 11.5% to Rs 62.

TBO Tek shares gain 3%; Nuvama initiates 'Buy' with Rs 2,200 target

Shares of travel tech firm TBO Tek rose nearly 3% on Thursday to Rs 1,733 after brokerage Nuvama initiated coverage with a Buy rating and a Rs 2,200 target price. The brokerage expects a 35% earnings CAGR over FY27-FY29E, driven by international expansion and hotel business growth.

Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target price

Jefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correction driven by regulatory concerns over drug and consumable price caps. The brokerage expects strong fundamentals and strategic price adjustments to help limit long-term EBITDA impact.

Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?

Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600 target price, implying 27% upside from Tuesday’s close and nearly 98% above its Rs 807 IPO price. The stock had listed at a 21% premium at Rs 980.

Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s why

Lenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA margin improved to 21.7%, with growth across domestic and international markets. The company also reported strong demand for both affordable and premium eyewear, highlighting the scaling potential of its international business.

FIIs dump telecom for 8th straight month, outflows cross Rs 32,000 crore. Are stocks set for rebound?

Foreign portfolio investors have dumped Indian telecom stocks for the eighth consecutive month, pulling out over Rs 32,000 crore in CY26. Heavy 5G capex, delayed tariff hikes, and legal dues weigh on cash flows, leaving market participants questioning if a stock rebound is near.

Goldman Sachs, BNP Paribas divest over 68 lakh BSE shares worth Rs 2,186 crore ahead of Nifty 50 inclusion

Goldman Sachs and BNP Paribas divested 68.33 lakh shares of BSE through bulk deals on the NSE. The combined sale amounted to approximately Rs 2,186.44 crore and occurred before BSE's entry into the Nifty 50 index. UTI Mutual Fund and Nippon India Mutual Fund purchased a total of 52.43 lakh shares of BSE. BSE shares ended 3.31% higher at Rs 3,200, reflecting significant market interest.

BSE shares rise 2% ahead of Nifty 50 entry tomorrow. Top brokerages share mixed outlook

BSE shares rose ahead of their Nifty 50 inclusion, with the move expected to trigger significant passive fund inflows. While Macquarie remains bullish on BSE’s growth prospects, Jefferies and Nuvama flag regulatory changes, CAS and trading-related headwinds.

BSE set to enter Nifty 50 from tomorrow, IT major Wipro to exit. What shareholders must know?

BSE has been included in the Nifty 50 after its six-month average free-float market capitalisation came in at Rs 1,40,879 crore. This is at least 1.5 times the six-month average free-float market capitalisation of the smallest constituent in the eligible universe, Wipro, whose average free-float market capitalisation stood at Rs 55,930 crore, according to the NSE release in August.

Goldman Sachs sees Eternal achieving $1 billion EBITDA by FY29; raises target price

Goldman Sachs maintained a Buy rating on Eternal, formerly Zomato, raising its target price by 11% to Rs 385. The brokerage foresees Eternal hitting $1 billion EBITDA by FY29, driven by Blinkit's robust growth and steady-state margin expansion alongside stabilising competitive intensity in quick commerce.

NSE shares fall 2%, slip below IPO price, but analysts’ target prices go up to Rs 2,050. Time to buy?

NSE slipped below their Rs 1,785 IPO price on Monday, taking its market capitalisation to Rs 4.36 lakh crore. Despite the decline, brokerages remain positive on the stock, with Macquarie, Emkay and PL Capital setting target prices between Rs 1,950 and Rs 2,050, citing its market leadership and growth prospects.

BSE shares fall 2%, down 30% in 4 months. Why Macquarie is bullish while Jefferies is cautious

BSE shares fell over 2% amid a broader market decline, trading more than 30% below their May high. Brokerages offered mixed views, with Macquarie bullish on growth prospects, while Jefferies and Nuvama flagged regulatory and operational headwinds, including STT changes, RBI norms and the Closing Auction Session impact.

Stocks to buy: Macquarie initiates Outperform rating on these 4 capital market stocks. Do you own any?

NSE shares fall 2%, trade marginally above IPO price after debut. Why are Macquarie, other brokerages bullish?

NSE shares fell by 1.6% to Rs 1,790 following its stock market debut on Thursday. Brokerages Macquarie and Emkay assigned positive ratings, citing growth potential and resilient market leadership. NSE's market capitalisation now ranks among the largest firms in India. Analysts expect varying revenue growth rates for transaction income and diversified revenue streams. Overall, optimistic projections suggest significant upside potential for NSE shares in the coming years.

NSE shares list with gains on debut day: How much Radhakishan Damani, Raamdeo Agrawal & other ace investors’ stakes are now worth

NSE shares gained up to 5% on debut day, lifting the value of stakes held by ace investors including Radhakishan Damani, Dolly Khanna, Raamdeo Agrawal and Motilal Oswal. Damani’s 1.58% stake was worth over Rs 7,340 crore at the day’s high, while brokerages retained a positive outlook on NSE.

Didn’t get NSE IPO shares? Should you buy after listing, wait for a dip or bet on BSE?

NSE Shares: As the National Stock Exchange (NSE) emerges on the market, investors are presented with various investment avenues. Options include buying shares, waiting for strategic price dips, or exploring the rival BSE. Experts advise thorough assessment of market fluctuations and valuations. Long-term investors should consider a gradual approach to accumulating shares, taking into account NSE's dominance, while still evaluating BSE’s promising prospects and operational frameworks.

NSE draws brokerage attention on stock market debut as 3 firms initiate coverage on Day 1

NSE shares rallied after a muted listing at Rs 1,800, pushing the exchange into India’s ninth-most valued company with a market cap of Rs 4.63 lakh crore. The post-listing surge came as three major brokerages initiated coverage on Day 1 with positive ratings. Macquarie called NSE “The Dominator” and assigned an Outperform rating with a Rs 1,965 target price.

NSE shares jump 5% after muted debut, market value swells by Rs 19,290 crore. Why Macquarie, other brokerages are bullish

NSE Share Price: National Stock Exchange shares made their market debut at Rs 1,800, which is slightly above the IPO price. The listing reflects a market capitalization exceeding Rs 4.45 lakh crore, significantly higher than BSE's Rs 1.33 lakh crore. The IPO aimed to raise Rs 22,562 crore through an offer for sale of shares by existing shareholders. Additionally, the shares had a grey market premium of 2% before listing.